Albion Financial Group UT Has $485,000 Stake in Sanofi (SNY)
Albion Financial Group UT maintained its position in shares of Sanofi (NYSE:SNY) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 10,128 shares of the company’s stock at the end of the second quarter. Albion Financial Group UT’s holdings in Sanofi were worth $485,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of the company. Fisher Asset Management LLC boosted its position in shares of Sanofi by 8.1% in the 2nd quarter. Fisher Asset Management LLC now owns 13,638,458 shares of the company’s stock worth $653,419,000 after purchasing an additional 1,022,953 shares during the last quarter. Bank of America Corp DE lifted its holdings in Sanofi by 8.2% during the first quarter. Bank of America Corp DE now owns 7,531,334 shares of the company’s stock worth $340,792,000 after acquiring an additional 572,652 shares in the last quarter. FMR LLC lifted its holdings in Sanofi by 3.0% during the second quarter. FMR LLC now owns 5,374,385 shares of the company’s stock worth $257,487,000 after acquiring an additional 155,751 shares in the last quarter. BlackRock Inc. lifted its holdings in Sanofi by 47.6% during the second quarter. BlackRock Inc. now owns 2,235,422 shares of the company’s stock worth $107,100,000 after acquiring an additional 720,523 shares in the last quarter. Finally, Parametric Portfolio Associates LLC lifted its holdings in Sanofi by 1.0% during the second quarter. Parametric Portfolio Associates LLC now owns 1,474,261 shares of the company’s stock worth $70,632,000 after acquiring an additional 13,981 shares in the last quarter. Institutional investors and hedge funds own 9.33% of the company’s stock.
In other Sanofi news, major shareholder Sanofi purchased 105,820 shares of the firm’s stock in a transaction on Thursday, August 24th. The stock was purchased at an average cost of $482.04 per share, for a total transaction of $51,009,472.80. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.00% of the company’s stock.
Sanofi (SNY) traded down 0.44% on Wednesday, reaching $49.88. The company’s stock had a trading volume of 1,147,397 shares. The stock’s 50 day moving average price is $49.29 and its 200 day moving average price is $48.09. Sanofi has a 12 month low of $36.81 and a 12 month high of $50.65. The company has a market cap of $125.95 billion, a P/E ratio of 11.58 and a beta of 0.87.
Sanofi (NYSE:SNY) last issued its quarterly earnings results on Monday, July 31st. The company reported $0.74 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.74. Sanofi had a return on equity of 25.34% and a net margin of 25.89%. The firm had revenue of $8.66 billion during the quarter, compared to the consensus estimate of $8.71 billion. The firm’s revenue was down 2.3% on a year-over-year basis. Equities research analysts forecast that Sanofi will post $3.33 earnings per share for the current year.
SNY has been the topic of several recent analyst reports. Argus reiterated a “buy” rating and set a $55.00 target price on shares of Sanofi in a report on Friday, September 1st. HSBC Holdings plc upgraded Sanofi from a “reduce” rating to a “hold” rating in a report on Wednesday, August 30th. BidaskClub upgraded Sanofi from a “hold” rating to a “buy” rating in a report on Friday, June 23rd. J P Morgan Chase & Co reiterated a “neutral” rating on shares of Sanofi in a report on Friday, September 15th. Finally, Zacks Investment Research lowered Sanofi from a “hold” rating to a “strong sell” rating in a report on Friday, October 6th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $53.50.
ILLEGAL ACTIVITY NOTICE: “Albion Financial Group UT Has $485,000 Stake in Sanofi (SNY)” was reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/10/11/albion-financial-group-ut-has-485000-stake-in-sanofi-sny.html.
Sanofi Company Profile
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.